Gossamer Bio, Inc.GOSSNASDAQ

Revenue (LTM)

$48M

-57.7% YoY

Net Income (LTM)

$-170M

-201.4% YoY

Free Cash Flow

$-171M

Revenue CAGR (5Y)

—

Marginsdeclining

FCF($0.2B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	0	115	48↓57.7%
Gross Profit	0	0	0	115	47↓58.6%
Operating Income	-216	-219↓1.1%	-184↑15.9%	-60↑67.4%	-163↓172.5%
Net Income	-234	-229↑2.0%	-180↑21.6%	-57↑68.6%	-170↓201.4%
EBITDA	-209	-211↓0.8%	-162↑23.3%	-40↑75.3%	-162↓306.0%
EPS Diluted	-3.33	-2.84↑14.7%	-1.18↑58.5%	-0.25↑78.8%	-0.75↓200.0%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	183	112↓38.9%	32↓71.3%	46↑43.5%	38↓18.1%
Total Current Assets	332	262↓21.1%	307↑17.0%	310↑1.1%	168↓45.9%
Total Assets	344	272↓20.7%	312↑14.5%	315↑1.1%	172↓45.4%
Total Current Liabilities	40	49↑23.5%	52↑4.8%	45↓12.8%	63↑40.9%
Total Liabilities	222	260↑17.2%	249↓4.3%	286↑14.7%	295↑3.2%
Total Equity	121	12↓90.1%	63↑419.7%	29↓53.0%	-123↓516.2%
Total Debt	185	226↑21.9%	212↓5.9%	203↓4.5%	202↓0.5%
Net Debt	2	114↑6103.2%	180↑58.5%	157↓13.1%	164↑4.7%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-189	-187↑1.0%	-159↑14.9%	-3↑97.8%	-171↓4838.5%
Capital Expenditure	-2	-0↑70.7%	0	0	-0
Free Cash Flow	-191	-188↑1.6%	-159↑15.1%	-3↑97.8%	-171↓4840.7%
Stock-Based Comp	32	43↑32.9%	29↓33.0%	21↓27.7%	11↓48.8%
Net Change in Cash	-303	-71↑76.4%	-80↓11.7%	14↑117.5%	-8↓159.7%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance